{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:46:47Z","timestamp":1792072007807,"version":"4.4.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title\/>\n                  <jats:p>Perimenopause is a clinically heterogeneous stage of reproductive aging with unique physiology distinct from menopause. It is variably defined, lacks specific guidelines or practice recommendations, and can be challenging for clinicians to manage. Patients may present with myriad symptoms, including mood and cognitive changes, abnormal uterine bleeding, sleep disruption, and vasomotor symptoms, as well as sexual concerns. Managing such complaints while taking into consideration contraceptive needs and evolving cardiometabolic risk can be nuanced. Hormonal contraceptives are commonly prescribed for the management of perimenopause symptoms, but they are not universally adequate or preferred. This clinical perspective provides a practical toolkit for clinicians, outlining the role of hormonal contraceptives for perimenopause care, alternative hormonal strategies, and options for individualizing treatment through shared decision making.<\/jats:p>","DOI":"10.1097\/aog.0000000000006436","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:00:40Z","timestamp":1789502440000},"page":"571-583","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal Options for Perimenopause"],"prefix":"10.1097","volume":"148","author":[{"given":"Jaclyn","family":"Piasta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Zewail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"R1-20261015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00404-025-08116-1","article-title":"Investigation of the quality of life and influencing factors among perimenopausal women","volume":"312","author":"Liu","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"R2-20261015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/GME.0000000000000736","article-title":"Duration of the menopausal transition is longer in women with young age at onset: the Multiethnic Study of Women's Health Across the Nation","volume":"24","author":"Paramsothy","year":"2017","journal-title":"Menopause"},{"key":"R3-20261015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R4-20261015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2022.24140","article-title":"Management of menopausal symptoms: a review","volume":"329","author":"Crandall","year":"2023","journal-title":"JAMA"},{"key":"R5-20261015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"key":"R6-20261015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","article-title":"The menopause transition: signs, symptoms, and management options","volume":"106","author":"Santoro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20261015","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20261015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/GME.0000000000002339","article-title":"\u201cNot feeling like myself\u201d in perimenopause\u2014what does it mean? Observations from the Women Living Better survey","volume":"31","author":"Coslov","year":"2024","journal-title":"Menopause"},{"key":"R9-20261015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S2213-8587(25)00138-X","article-title":"Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study","volume":"13","author":"Islam","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R10-20261015","doi-asserted-by":"crossref","first-page":"r1695","DOI":"10.1136\/bmj.r1695","article-title":"Menopause misinformation is harming care","volume":"390","author":"Christakis","year":"2025","journal-title":"BMJ"},{"key":"R11-20261015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/GRF.0000000000000389","article-title":"Management of the perimenopause","volume":"61","author":"Delamater","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R12-20261015","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/jc.2007-0066","article-title":"Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Stages of Reproductive Aging Workshop staging system","volume":"92","author":"Hale","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20261015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/gme.0b013e31817ee0c2","article-title":"Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition","volume":"16","author":"Hale","year":"2009","journal-title":"Menopause"},{"key":"R14-20261015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ogc.2011.05.004","article-title":"Reproductive hormones and the menopause transition","volume":"38","author":"Santoro","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R15-20261015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1474-4422(20)30482-8","article-title":"Menstrual migraine: a distinct disorder needing greater recognition","volume":"20","author":"Vetvik","year":"2021","journal-title":"Lancet Neurol"},{"key":"R16-20261015","doi-asserted-by":"crossref","first-page":"105851","DOI":"10.1016\/j.psyneuen.2022.105851","article-title":"Baseline anxiety-sensitivity to estradiol fluctuations predicts anxiety symptom response to transdermal estradiol treatment in perimenopausal women\u2014a randomized clinical trial","volume":"143","author":"Lozza-Fiacco","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"R17-20261015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11920-021-01285-1","article-title":"Premenstrual mood symptoms in the perimenopause","volume":"23","author":"Sander","year":"2021","journal-title":"Curr Psychiatry Rep"},{"key":"R18-20261015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/jwh.2015.5556","article-title":"Perimenopause: from research to practice","volume":"25","author":"Santoro","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"R19-20261015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"R20-20261015","doi-asserted-by":"crossref","first-page":"G49","DOI":"10.1093\/ejendo\/lvaf206","article-title":"European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause","volume":"193","author":"Lumsden","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"R21-20261015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.fertnstert.2024.11.007","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"123","author":"Panay","year":"2025","journal-title":"Fertil Steril"},{"key":"R22-20261015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-m\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum Reprod Update"},{"key":"R23-20261015","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/AOG.0000000000005395","article-title":"Compounded bioidentical menopausal hormone therapy. ACOG Clinical Consensus No. 6. American College of Obstetricians & Gynecologists","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R24-20261015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"R25-20261015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mayocpiqo.2023.11.004","article-title":"Foundations of lifestyle medicine and its evolution","volume":"8","author":"Lippman","year":"2024","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"R26-20261015","doi-asserted-by":"crossref","first-page":"e072612","DOI":"10.1136\/bmj-2022-072612","article-title":"Management of perimenopausal and menopausal symptoms","volume":"382","author":"Duralde","year":"2023","journal-title":"BMJ"},{"key":"R27-20261015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(23)02799-X","article-title":"An empowerment model for managing menopause","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"key":"R28-20261015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"key":"R29-20261015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/1471-0528.16524","article-title":"Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis","volume":"128","author":"Mishra","year":"2021","journal-title":"BJOG"},{"key":"R30-20261015","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJMcp0708481","article-title":"Hormonal contraception in women of older reproductive age","volume":"358","author":"Kaunitz","year":"2008","journal-title":"N Engl J Med"},{"key":"R31-20261015","doi-asserted-by":"crossref","first-page":"2543423","DOI":"10.1080\/09513590.2025.2543423","article-title":"Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraception","volume":"41","author":"Genazzani","year":"2025","journal-title":"Gynecol Endocrinol"},{"key":"R32-20261015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/GCO.0000000000000667","article-title":"Perimenopausal contraception","volume":"32","author":"Voedisch","year":"2020","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R33-20261015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/13697137.2023.2258783","article-title":"The 2023 practitioner's toolkit for managing menopause","volume":"26","author":"Davis","year":"2023","journal-title":"Climacteric"},{"key":"R34-20261015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/GME.0000000000002554","article-title":"Contraception in perimenopause","volume":"32","author":"Soltes","year":"2025","journal-title":"Menopause"},{"key":"R35-20261015","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","author":"Roach","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R36-20261015","doi-asserted-by":"crossref","first-page":"110310","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"R37-20261015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/IJWH.S288070","article-title":"Contraception during perimenopause: practical guidance","volume":"14","author":"Grandi","year":"2022","journal-title":"Int J Womens Health"},{"key":"R38-20261015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0045-1811951","article-title":"Hormonal contraception in perimenopause: what to consider to guide the choice","volume":"43","author":"Fidecicchi","year":"2025","journal-title":"Semin Reprod Med"},{"key":"R39-20261015","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"6","author":"Ma","year":"2023","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R40-20261015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/AOG.0b013e318277c93b","article-title":"Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Committee Opinion No. 540. American College of Obstetricians & Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R41-20261015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"R42-20261015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/GME.0000000000002407","article-title":"Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials","volume":"31","author":"Yang","year":"2024","journal-title":"Menopause"},{"key":"R43-20261015","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15211","article-title":"Update on menopause hormone therapy: current indications and unanswered questions","author":"Mukherjee","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R44-20261015","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.3390\/jcm14207156","article-title":"Reconsidering hormone replacement therapy: current insights on utilisation in premenopausal and menopausal women: an overview","volume":"14","author":"Yanachkova","year":"2025","journal-title":"J Clin Med"},{"key":"R45-20261015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab011","article-title":"Hormone therapy in menopause: concepts, controversies, and approach to treatment","volume":"42","author":"Flores","year":"2021","journal-title":"Endocr Rev"},{"key":"R46-20261015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/01.AOG.0000428645.90795.d9","article-title":"Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism. Committee Opinion No. 556. American College of Obstetricians & Gynecologists","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R47-20261015","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"R48-20261015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"R49-20261015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","article-title":"Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death","volume":"37","author":"Arnesen","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R50-20261015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamainternmed.2013.11074","article-title":"Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens","volume":"174","author":"Smith","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R51-20261015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.maturitas.2023.04.004","article-title":"Oral estradiol\/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens\/medroxyprogesterone acetate in real-world practice","volume":"172","author":"Panay","year":"2023","journal-title":"Maturitas"},{"key":"R52-20261015","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1038\/s41598-021-90357-6","article-title":"Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"R53-20261015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(99)00021-3","article-title":"Absorption and bioavailability of oestradiol from a gel, a patch and a tablet","volume":"32","author":"J\u00e4rvinen","year":"1999","journal-title":"Maturitas"},{"key":"R54-20261015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/ENDO:26:3:297","article-title":"Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation","volume":"26","author":"Prior","year":"2005","journal-title":"Endocrine"},{"key":"R55-20261015","first-page":"1495","article-title":"Characterization of reproductive hormonal dynamics in the perimenopause","volume":"81","author":"Santoro","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20261015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/CS20060228","article-title":"Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy","volume":"112","author":"Prior","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"R57-20261015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/gme.0b013e318247f07a","article-title":"Oral micronized progesterone for vasomotor symptoms\u2014a placebo-controlled randomized trial in healthy postmenopausal women","volume":"19","author":"Hitchcock","year":"2012","journal-title":"Menopause"},{"key":"R58-20261015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reprod Sci"},{"key":"R59-20261015","doi-asserted-by":"crossref","first-page":"101815","DOI":"10.1016\/j.beem.2023.101815","article-title":"Progestogens for endometrial protection in combined menopausal hormone therapy: a systematic review","volume":"38","author":"Stute","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R60-20261015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"R61-20261015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/13697137.2018.1446931","article-title":"Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis","volume":"21","author":"Scarabin","year":"2018","journal-title":"Climacteric"},{"key":"R62-20261015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13643-016-0294-5","article-title":"Progesterone vs synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Asi","year":"2016","journal-title":"Syst Rev"},{"key":"R63-20261015","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1210\/clinem\/dgaa873","article-title":"Efficacy of micronized progesterone for sleep: a systematic review and meta-analysis of randomized controlled trial data","volume":"106","author":"Nolan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-20261015","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1038\/s41598-023-35826-w","article-title":"Oral micronized progesterone for perimenopausal night sweats and hot flushes: a phase III Canada-wide randomized placebo-controlled 4-month trial","volume":"13","author":"Prior","year":"2023","journal-title":"Sci Rep"},{"key":"R65-20261015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13697137.2018.1446932","article-title":"Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy","volume":"21","author":"Gompel","year":"2018","journal-title":"Climacteric"},{"key":"R67-20261015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/13697137.2020.1806816","article-title":"Uterine bleeding with hormone therapies in menopausal women: a systematic review","volume":"23","author":"Pickar","year":"2020","journal-title":"Climacteric"},{"key":"R68-20261015","doi-asserted-by":"crossref","first-page":"2020-10-1","DOI":"10.7573\/dic.2020-10-1","article-title":"Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference","volume":"9","author":"Stevenson","year":"2020","journal-title":"Drugs Context"},{"key":"R69-20261015","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMra2202438","article-title":"Sex hormone influences on venous thrombotic and cardiovascular risk","volume":"394","author":"Skeith","year":"2026","journal-title":"N Engl J Med"},{"key":"R70-20261015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/GME.0000000000002672","article-title":"Use of progestin-containing intrauterine systems in hormone therapy regimens: what are the data?","volume":"33","author":"Voedisch","year":"2026","journal-title":"Menopause"},{"key":"R71-20261015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/gme.0b013e31821606c5","article-title":"Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis","volume":"18","author":"Somboonporn","year":"2011","journal-title":"Menopause"},{"key":"R73-20261015","first-page":"e251","article-title":"Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 186. American College of Obstetricians & Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R74-20261015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14656566.2018.1462337","article-title":"Levonorgestrel-releasing intra-uterine systems as female contraceptives","volume":"19","author":"Grandi","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 1","key":"R75-20261015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/humrep\/15.suppl_1.149","article-title":"Vaginal progesterone in menopause: crinone 4% in cyclical and constant combined regimens","volume":"15","author":"de Ziegler","year":"2000","journal-title":"Hum Reprod"},{"key":"R76-20261015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2021.09.002","article-title":"Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women","volume":"154","author":"Sriprasert","year":"2021","journal-title":"Maturitas"},{"key":"R77-20261015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/13697137.2016.1187123","article-title":"The impact of micronized progesterone on the endometrium: a systematic review","volume":"19","author":"Stute","year":"2016","journal-title":"Climacteric"},{"key":"R78-20261015","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/AOG.0000000000006275","article-title":"Updated guidance regarding the role of transvaginal ultrasonography in evaluating the endometrium of individuals with postmenopausal bleeding","volume":"148","year":"2026","journal-title":"Obstet Gynecol"},{"key":"R79-20261015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/TCRM.S63833","article-title":"Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene","volume":"12","author":"Kagan","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"R80-20261015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.contraception.2012.12.011","article-title":"Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment","volume":"87","author":"Stanczyk","year":"2013","journal-title":"Contraception"},{"key":"R81-20261015","first-page":"150096","article-title":"Estradiol: micrograms or milligrams","volume":"2016","author":"Kirk","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"R82-20261015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"R83-20261015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40266-019-00700-w","article-title":"Practical treatment considerations in the management of genitourinary syndrome of menopause","volume":"36","author":"Kagan","year":"2019","journal-title":"Drugs Aging"},{"key":"R84-20261015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/JU.0000000000004589","article-title":"The AUA\/SUFU\/AUGS guideline on genitourinary syndrome of menopause","volume":"214","author":"Kaufman","year":"2025","journal-title":"J Urol"},{"key":"R90-20261015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1891\/CJNPWH-2510","article-title":"Understanding and prescribing menopausal hormone therapy for vasomotor symptoms","volume":"2","author":"Quaile","year":"2025","journal-title":"Clin J Nurse Pract Womens Health"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:02:59Z","timestamp":1792069379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006436"}},"subtitle":["A Clinician Toolkit"],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006436","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"2026-04-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}